Serratiopeptidase is a proteolytic enzyme preparation used in pharmaceutical manufacturing. It is under clinical investigation for its anti-inflammatory properties, particularly in postoperative settings.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 37312-62-2
Metoprolol
pharmaceutical raw material
Tropine benzylate
pharmaceutical raw material
Disopyramide
pharmaceutical raw material
Mycophenolate sodium
pharmaceutical raw material
(11Z)-17-hydroxy-2-phenyl-9-oxa-1,5,14,21-tetrazatetracyclo[12.7.1.03,8.016,21]docosa-3(8),4,6,11,16,19-hexaene-15,18-dione
ZKKJCEMUENOBKY-KERYXKJGSA-N
C/1N2C(=O)C3=C(C(=O)C=CN3N(C2)C(C4=C(OC/C=C1)C=CN=C4)C5=CC=CC=C5)O.C/1N2C(=O)C3=C(C(=O)C=CN3N(C2)C(C4=C(OC/C=C1)C=CN=C4)C5=CC=CC=C5)O